Mitalipov OHSU Human SCNT + Germline Pipeline (2007-2026)
mechanismBiotech & Transhumanism
The main US lab pushing to edit human embryos keeps its riskiest steps just offshore to dodge American bans.
Who they are
The Oregon lab of Shoukhrat Mitalipov at Oregon Health & Science University, the leading continued US site for human cloning-technique and gene-correction research.
What they do
The engine tracks it as a steady Western academic push toward editing the human genetic line, with the boldest clinical steps moved abroad.
How it works
The lab cloned human cells to an early embryo stage in 2013 and pioneered 'three-parent IVF' in 2016 — but the first actual birth was done in Mexico under Dr. John Zhang because a US budget rule bans such clinical trials; by 2025 the lab published papers advocating CRISPR gene correction in early embryos.
Why it matters
It shows a continuous academic drive toward human germline editing, with the technology migrating offshore whenever US law blocks the clinical step at home.
The engine's record — word for word
Shoukhrat Mitalipov's laboratory at Oregon Health & Science University is the primary continued US node for human SCNT and germline correction research. 2013: human SCNT to blastocyst stage (Cell). 2016: spindle-transfer mitochondrial replacement therapy (three-parent IVF) — first live birth executed in Mexico under Dr John Zhang's direction due to FDA appropriations rider prohibiting US germline clinical trials. 2025: Nature Communications + Fertility and Sterility papers advocating targeted CRISPR-Cas9 correction of inherited mutations in preimplantation embryos. Engine framing: DNA-as-Transducer divergence substrate instance — enucleated oocyte provides the natural reprogramming environment that biochemical-determinist paradigm cannot model. Continuous Western academic-tier push toward human germline editing, technology migrating offshore for clinical execution.
Follow the trail
Walk this on the live map →